Surgical Site Infection Clinical Trial
Official title:
Surgical Site Infection in Obese Women After Cesarean Section; A Randomized Controlled Trial of Absorbable Versus Non Absorbable Sutures for Skin Closure.
The purpose of this study is to determine the surgical site infection rate and patient satisfaction for absorbable versus non absorbable suture in closure of skin at cesarean section in obese women.
Cesarean section (CS) is the commonest major operation performed on women in the world.
Approximately one in 4 women in the United States is delivered by cesarean section, and it
is well established that operative abdominal delivery is associated with a significant risk
of infection compared with vaginal delivery. These risks are increased with preexisting
operative site infection, breaks in sterile technique, prolonged preoperative admissions
that may result in colonization with resistant microbes, prolonged operative duration, use
of electrocautery, obesity, advanced age, inadequate host immunocompetence.
Obese women may have increased susceptibility to infections because of the effects of
obesity on the immune system, skin barriers, wound healing, mobility, and coexisting chronic
diseases including diabetes, which could increase infection risk by itself. Cohort studies
have shown that women with a body mass index (BMI)>30kg/m^2 have a two to three folds
increased risk of post cesarean infections, such as wound infection, urinary tract infection
UTI), endometritis, or pneumonia, compared with non-obese women. Other studies found that
obesity doubled the risk specifically for post-cesarean wound infection.
Wound complications are a major source of morbidity after CS and contribute to prolonged
hospital stay and rates of readmission. Age, (BMI), length of incision, and timing of
prophylactic antibiotic administration have all been associated with post cesarean surgical
site infection (SSI).
A surgical site infection is an infection that occurs after surgery in the part of the body
where the surgery took place. SSI can sometimes be superficial infections involving the skin
only. Other surgical site infections are more serious and can involve tissues under the
skin, organs, or implanted material. SSI has a great impact on the economy and health care
resources. Infection has always been a feature of modern surgery and continues to be a
significant problem for health care practitioners across the world.
The ideal skin closure would be safe and effective, associated with minimal patient
discomfort, and have a good cosmetic result. It would also be inexpensive and require fewer
health care resources by being fast and easy to apply, require minimal follow-up evaluation,
and be associated with a low rate of complications.
Methods for closing the skin at the time of cesarean delivery include stainless steel
staples, subcuticular absorbable staples, subcuticular suture, adhesive closure strips, and
tissue adhesives (cyanoacrylates). Each of the methods has its postulated benefits for wound
outcomes; however, none of these have been compared in a prospective trial.
The role of skin closure suture material on wound complication rates in Obstetrics is poorly
studied. And when we are talking about obese patients we did not find any recommendation
regarding the suture material of skin closure although most of Obstetricians use different
sutures materials.
Does closure of skin by absorbable compared to non absorbable suture affect the rate of
surgical site infection in obese patients undergoing caesarian section? Our hypothesis is
that no difference between absorbable compared to non absorbable suture.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04096885 -
The Inselspital Surgical Cohort Study
|
||
Terminated |
NCT03820648 -
Wound Protector Dual-ring Alexis® in Pancreaticoduodenectomy
|
N/A | |
Completed |
NCT04067843 -
Effect of Photodynamic Treatment on Skin Microbiome. Single Center Study
|
N/A | |
Terminated |
NCT04042077 -
Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections
|
Phase 3 | |
Completed |
NCT05841576 -
Anaesthetic Management Guided by COMET Measurements
|
N/A | |
Withdrawn |
NCT05338281 -
NPWT for Abdominal Incisions in DIEP Reconstructions: A RCT
|
N/A | |
Recruiting |
NCT03042091 -
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
|
Early Phase 1 | |
Completed |
NCT01697748 -
Prospective Study on Cesarean Wound Outcomes
|
N/A | |
Terminated |
NCT01789697 -
Text Message Study
|
N/A | |
Recruiting |
NCT05966961 -
Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery
|
||
Recruiting |
NCT05077592 -
Addition of Pre-wound Closure Povidone Iodine Wash Versus Direct Wound Closure Effect on Surgical Site Infections
|
Phase 4 | |
Recruiting |
NCT05502380 -
Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery
|
Phase 3 | |
Recruiting |
NCT05763602 -
PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)
|
Phase 4 | |
Recruiting |
NCT03221023 -
Intrawound Vancomycin Prophylaxis for Neural Stimulator
|
Phase 2/Phase 3 | |
Completed |
NCT03257202 -
Topical Treatment and Prevalence of P. Acnes
|
Phase 2 | |
Completed |
NCT06154720 -
Surgical Site Infection After Episiotomy Repair Related to Routine Use of Antibiotic Prophylaxis in Low-Risk Population
|
||
Not yet recruiting |
NCT06465901 -
A Stratified, Multi-ARm, muLti-site Randomised Platform Trial Aiming to Reduce the INcidence of Post-operative SSI
|
N/A | |
Not yet recruiting |
NCT04820075 -
Efficacy of an Intervention to Improve the Preoperative Shower in Scheduled Surgery
|
N/A | |
Recruiting |
NCT03561376 -
Zinc Oxide Versus Petrolatum Following Skin Surgery
|
Early Phase 1 | |
Not yet recruiting |
NCT04496180 -
Prevena to Prevent Surgical Site Infection After Emergency Abdominal Laparotomy
|
N/A |